Identification of glycolipid receptors for Helicobacter pylori by TLC-immunostaining. 1991

T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

Helicobacter pylori has been identified as a causative agent in active chronic gastritis. The receptor for this bacteria, however, is not known. It is likely that the receptor molecules may be glycosphingolipids as shown in the cases of other bacteria. We explored this possibility by a thin-layer chromatography (TLC)-immunostaining method. Among glycosphingolipids extracted from human gastric mucosa, intact Helicobacter pylori specifically bound to I3SO3-GalCer and II3NeuAc-LacCer, whereas no specific binding to neutral glycosphingolipids, which share the same ceramide moiety with I3SO3-GalCer or II3NeuAc-LacCer, was demonstrated. Sonicated bacteria could still bind to II3NeuAc-LacCer with comparable affinity. In contrast, the binding of bacteria to I3SO3-GalCer was greatly diminished upon sonication. These results suggest that each of the oligosaccharide moieties of II3NeuAc-LacCer and I3SO3-GalCer may be specifically recognized by different ligand molecules of Helicobacter pylori.

UI MeSH Term Description Entries
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001422 Bacterial Adhesion Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesion, Bacterial,Adhesions, Bacterial,Bacterial Adhesions
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
October 1999, Biochimica et biophysica acta,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
December 1993, Nihon rinsho. Japanese journal of clinical medicine,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
January 2002, FEMS immunology and medical microbiology,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
January 2014, Methods in molecular biology (Clifton, N.J.),
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
April 1993, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
April 1994, Journal of the neurological sciences,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
April 1998, The Journal of infectious diseases,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
February 2007, Biomedical chromatography : BMC,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
February 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
T Saitoh, and H Natomi, and W L Zhao, and K Okuzumi, and K Sugano, and M Iwamori, and Y Nagai
January 1999, Pathology oncology research : POR,
Copied contents to your clipboard!